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RIP1 autophosphorylation is promoted
by mitochondrial ROS and is essential for RIP3
recruitment into necrosome
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Necroptosis is a type of programmed cell death with great signiﬁcance in many pathological
processes. Tumour necrosis factor-a(TNF), a proinﬂammatory cytokine, is a prototypic trigger
of necroptosis. It is known that mitochondrial reactive oxygen species (ROS) promote
necroptosis, and that kinase activity of receptor interacting protein 1 (RIP1) is required for
TNF-induced necroptosis. However, how ROS function and what RIP1 phosphorylates to
promote necroptosis are largely unknown. Here we show that three crucial cysteines in RIP1
are required for sensing ROS, and ROS subsequently activates RIP1 autophosphorylation on
serine residue 161 (S161). The major function of RIP1 kinase activity in TNF-induced
necroptosis is to autophosphorylate S161. This speciﬁc phosphorylation then enables RIP1 to
recruit RIP3 and form a functional necrosome, a central controller of necroptosis. Since ROS
induction is known to require necrosomal RIP3, ROS therefore function in a positive feedback
circuit that ensures effective induction of necroptosis.
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ecroptosis is a form of programmed cell death character-
ized by cellular organelle swelling and cell membrane
rupture, which is mediated by the necrotic signalling
complex necrosome1–4. Substantial evidence has accumulated to
show that necroptosis is involved in diseases caused by viral and
bacterial infections, as well as sterile injury-induced inﬂammatory
disorders5. Tumour necrosis factor (TNF) is a physiologically and
pathologically signiﬁcant cytokine and is widely associated
with necroptosis. Upon binding to TNF receptor 1 (TNFR1),
TNF stimulates the sequential formation of signalling complexes
in necroptosis: complex I and necrosome5–8. During the process
of necroptosis, RIP3 recruits and phosphorylates mixed lineage
kinase domain-like protein (MLKL)9,10. Phosphorylated MLKL
then undergoes oligomerization and translocates to the plasma
membrane to execute cell death11–14.
Protein phosphorylation plays an essential role in regulating
diverse cellular processes including TNF-induced necroptosis. It
is well known that RIP1, RIP3 and MLKL, three key components
in the necroptotic pathway, are phosphorylated during necrop-
tosis execution. The phosphorylation sites in RIP3 and MLKL and
the function of their phosphorylation have been well documen-
ted9,15,16. It is also clear that RIP1 kinase activity is involved in
necroptosis6,17 and that RIP1 can be autophosphorylated17,18.
However, the precise pathway leading to RIP1 autophospho-
rylation and its function in necroptosis are still unclear.
Reactive oxygen species (ROS) have long been considered as a
driving force for necroptosis and also participate in apopto-
sis19,20. For example, it has been demonstrated that TNF can
induce mitochondrial ROS and ROS enhance necrosome
formation21,22. Either elimination of ROS by scavengers such as
butylated hydroxyanisole (BHA), or inhibition of the electron
transport chain by inhibitors such as amytal (also known as
amobarbital) can inhibit TNF-induced necroptosis19,23–27. In
addition, the importance of ROS in inducing necroptosis has also
been veriﬁed in vivo in a model of tuberculosis-infected
zebraﬁsh28. However, BHA has no effect on TNF plus zVAD
and Smac mimetics-induced necroptosis in HT-29 cells,
suggesting that ROS are not involved in the necroptosis of
HT-29 cells7. And a recent study showed that deletion of
mitochondria by mitophagy does not compromise necroptosis in
SVEC or 3T3-SA cells29.
In this study we ﬁrst conﬁrmed that mitochondria are essential
for TNF-induced necroptosis in the majority of cell types tested.
We then discovered that RIP1 can sense ROS via modiﬁcation of
three crucial cysteine residues and its autophosphorylation on
S161 is induced subsequently. This phosphorylation event allows
efﬁcient recruitment of RIP3 to RIP1 to form a functional
necrosome. In short, our data uncovered RIP1 as the primary
target of mitochondrial ROS in necroptosis, and solved a long-
standing question of why RIP1 kinase activity is required for
necroptosis.
Results
ROS target site is at or downstream of RIP1. Published studies
suggested that mitochondrial ROS participate in necroptosis in
some but not all kinds of cells7,8,23,25,30,31. A recent work utilized
Parkin-induced mitophagy of mitochondria lacking membrane
potential to deplete mitochondria and observed that mitocho-
ndria depletion did not compromise TNF-induced necroptosis in
3T3-SA and SVEC cells29. Since depletion of respiration chain by
ethidium bromide inhibited TNF-induced necroptosis in L929
cells26, we tested the effect of Parkin-mediated mitochondrial
depletion in L929 cells. Benzyloxycarbonyl-Val-Ala-Aspﬂuoro-
methylketone (zVAD) was included in the experiment to exclude
apoptosis. Depletion of mitochondria was executed successfully as
indicated by the reduction of TOM20 protein level, oxygen
consumption and mito-tracker staining (Supplementary
Fig. 1a–c). As shown in Fig. 1a, removal of mitochondria by
Parkin-mediated mitophagy in L929 cells compromised
TNF-induced necroptosis, supporting the idea of cell context
dependence of ROS involvement. The incomplete inhibition of
necroptosis by mitochondria depletion might be due to the
incomplete removal of mitochondria (Supplementary Fig. 1a–c).
BHA is widely used to assay the involvement of ROS in cell
death and amytal is often applied to prove the involvement
of mitochondrial respiration in cell death19. We utilized these
inhibitors to verify that ROS involvement in necroptosis is cell
context-dependent (Supplementary Fig. 1d–e). Consistent with
previous reports19,25,30,31, we observed inhibition of necroptosis
by BHA and amytal in L929 cells, HeLa cells containing
overexpressed RIP3 (HeLa-RIP3), U937, A cells overexpressed
with RIP3 (A cell-RIP3), N cells, primary peritoneal
macrophages, and MEF, but not HT-29 cells, which correlated
with whether TNF induced ROS production in the given cell
(Supplementary Fig. 1d–e). We also tested the effect of these
inhibitors on L929 cells with or without mitochondria depletion,
and found that BHA or amytal blocked cell death to the same
survival level in mitochondria-depleted and not depleted L929
cells (Fig. 1b), indicating that BHA- or amytal-mediated
inhibition overlaps the inhibition mediated by mitochondria
depletion. Although BHA has other effect such as inhibition of
lipoxygenases32, to simplify our experimental procedure, we still
used BHA and amytal in the rest of this study to evaluate the
effect of mitochondrial ROS in necroptosis of L929 cells.
Since artiﬁcially induced dimerization/oligomerization of
signalling molecules in necroptotic pathway can cause necropto-
sis33–35, we used this method to examine whether the targeting
site of ROS is downstream of TNFR1, RIP1, RIP3 or MLKL. The
dimerization/oligomerization system used in our experiments was
based on anti-estrogen 4-hydroxytamxifen (4-OHT)-induced
homo-dimerization of hormone-binding domain’s G521R
mutant (HBD*) of estrogen receptor36. Here, we generated
expression vectors of HBD* fused with TNFR1 intracellular
domain (tTNFR1), RIP1 without C-terminal death domain
(RIP1DDD), RIP3 RHIM mutant (RIP3-RHIMmut) or MLKL
N-terminal domain (MLKLDPD) (Fig. 1c), and expressed these
fusion proteins in their corresponding knockout (KO) L929 cell
lines. Treatment of 4-OHT can efﬁciently induce oligomeri-
zation of tTNFR1 (Supplementary Fig. 1f), RIP1DDD (Supple-
mentary Fig. 1g), RIP3-RHIMmut (Supplementary Fig. 1h) and
MLKLDPD12. As anticipated, 4-OHT induced death of cells
expressing HBD*-tTNFR1, and both BHA and amytal inhibited
tTNFR1 oligomerization-mediated cell death (Fig. 1d). Similarly,
oligomerization of RIP1DDD-HBD* caused cell death and both
BHA and amytal inhibited it (Fig. 1e). In contrast, the oligo-
merization of RIP3-RHIMmut-HBD*- or MLKLDPD-HBD*-
mediated cell death was not affected by BHA or amytal
(Fig. 1f,g). These data indicated that the targeting site of
mitochondrial ROS should be at or downstream of RIP1
oligomerization and upstream of RIP3 in the necroptotic
pathway.
Three cysteines on RIP1 are targeted by ROS. ROS often
modulate protein functions by modifying cysteines(C) such as
forming intramolecular disulﬁde bond within or intermolecular
disulﬁde bond between the given proteins37. To examine the
involvement of cysteine modiﬁcation on RIP1 during necroptosis,
we analysed migration of RIP1 in SDS-PAGE under reducing and
non-reducing conditions. As shown in Fig. 2a, RIP1 was engaged
in a disulﬁde bond-linked high molecular weight complex/
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aggregate during TNF-induced necroptosis, because this complex
cannot be detected in b-mercaptoethanol-treated samples. The
formation of complex was inhibited by treating the cells with
BHA or amytal. Thus, ROS cause oxidation of RIP1 to form
intermolecular disulﬁde bonds.
To determine which cysteine(s) in RIP1 form(s) disulﬁde bond,
we ﬁrst mutated all the cysteines on RIP1 to serines, and
expressed this All-C-mutant in RIP1 KO L929 cells to evaluate
the role of cysteines in RIP1 in TNF-induced necroptosis. TNF-
induced necroptosis in All-C-mutant reconstituted cells was
much less than that in Flag-wildtype (WT) RIP1 reconstituted
cells and the All-C-mutant cells resisted to BHA and amytal
inhibition on necroptosis (Supplementary Fig. 2a), suggesting a
ROS-sensing function of cysteines in RIP1. To map the
cysteine(s) that respond(s) to ROS, we aligned RIP1 protein
sequences from different species and identiﬁed C34, C257, C268
and C586 as the conserved cysteines (Supplementary Fig. 2b).
Since C34 mutation has been made by others38, we focused on the
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Figure 1 | Mitochondrial ROS target a site(s) upstream of RIP3 and downstream of RIP1 oligomerization in TNF-induced necroptosis of L929 cells.
(a) Wildtype (WT) L929 cells transfected with Flag-Parkin expression vector or empty vector were treated with CCCP (10 mM) for 48 h. These cells,
together with corresponding CCCP non-treated control cells were treated with murine TNF (mTNF) þ zVAD for different periods of time as indicated.
Survival rate was determined by PI exclusion using ﬂow cytometry. The ﬁnal concentrations of mTNF and zVAD used in this paper were always 10 ng/ml
and 20mM, respectively, unless specially noted. (b) L929 cells expressing Flag-Parkin were treated with CCCP for 48 h. These cells, together with CCCP
non-treated control, were incubated with mTNF þzVAD for different periods of time. BHA or amytal was added 1 h before TNF stimulation. Viabilities were
measured with PI exclusion. The concentrations of BHA and amytal used in this paper were always 100 mM and 1mM, respectively. (c) Schematic
representation of HBD* fused tTNFR1, RIP1DDD, RIP3-RHIMmut and MLKLDPD. HBD* represents the mutated version with G521R, and RHIMmut stands for
RIP3 QIG449–451AAA mutation in RHIM domain. TM, KD, ID, DD are short for transmembrane, kinase domain, intermediate domain and death domain,
respectively. (d–g) Lentivirus encoding Flag-tagged HBD*-tTNFR1, RIP1DDD-HBD*, RIP3-RHIMmut-HBD* or MLKLDPD-HBD* was packaged in HEK293T
cells, and was used to infect corresponding gene KO L929 cells. These reconstituted L929 cells were then treated with 4-OHT (1mM) þ zVAD for the
indicated period of time with or without BHA/amytal. Viabilities were measured with PI exclusion. Data in (a,b) and (d,g) represented the mean±s.e.m. of
three independent experiments. **Po0.01; ns: no signiﬁcant difference. See also Supplementary Fig. 1.
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other three cysteines and generated a series of cysteine-to-serine
mutants. Only the simultaneous mutation of C257, C268 and
C586 to serines in RIP1 (termed 3CS) makes it insensitive to
BHA- and amytal-mediated inhibition of TNF-induced
necroptosis (Fig. 2b), though the other mutants were expressed
in comparable levels in RIP1 KO L929 cells (Fig. 2c). Inefﬁciency
of 3CS RIP1 in mediating necroptosis also supports the role of
these three cysteines in TNF-induced necroptosis.
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Figure 2 | C257, C268 and C586 residues in RIP1 are oxidized in response to TNF-induced ROS in L929 cells. (a) L929 cells were treated with
mTNFþzVAD for indicated periods of time with or without BHA/amytal. Western blotting of RIP1 with anti-RIP1 antibody was performed under reducing
(with b-Mercaptoethanol (b-Me)) and non-reducing (without b-Me) conditions (left panel). Cell viabilities were measured with PI exclusion (right panel).
Ox: oxidized form; Red: reduced form. (b) The three cysteines, C257, C268 and C586 in RIP1 were mutated to serines individually or in combination as
annotated. The Flag-tagged mutants were then expressed in RIP1 KO L929 cells by lentivirus vector for 24 h. Viabilities were measured by PI exclusion at
different time points after treatment of mTNFþzVAD with/without BHA or amytal. (c) The expression levels of reconstituted WTand mutant RIP1 in RIP1
KO cells in (b) were measured by western blotting with anti-RIP1 antibody. (d) RIP1 KO cells reconstituted with Flag-RIP1 or Flag-RIP1 3CS as in (b) were
treated with mTNFþzVAD for indicated periods of time. Western blotting of RIP1 was performed under non-reducing condition. (e) Oxidized RIP1 complex
was isolated from non-reducing SDS-PAGE and was analysed by MS. The cysteine residues, their redox statuses and the sequences of the tryptic peptides
containing those cysteines were summarized. For details see Fig. S2c. Data in (a,b) represented the mean±s.e.m. of three independent experiments.
**Po0.01; ns: no signiﬁcant difference. Data shown in (a,c,d) are representatives of two to three independent experiments. See also Supplementary Fig. 2.
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To conﬁrm that C257, C268 and C586 are responsible for
forming disulﬁde bonds in TNF-induced high molecular weight
RIP1 aggregate, we analysed RIP1 from WT and 3CS RIP1 cells
and found the complex was diminished by 3CS mutation
(Fig. 2d).
We then analysed the oxidative status of RIP1 cysteines in high
molecular weight RIP1 complex and RIP1 monomer. The
aggregate and monomer of WT RIP1 were cut from the non-
reducing SDS-PAGE gels and subjected to mass spectrometry
(MS) analysis. We detected seven cysteine-containing peptides
from RIP1 complex and found C257, C268 and C586 were
the only three cysteines in their oxidative status (Fig. 2e,
Supplementary Fig. 2c). All cysteines detected in the RIP1
monomer were in their reduced status. Collectively, our data
demonstrated that C257, C268 and C586 in RIP1 can form
intermolecular disulﬁde bonds, which is required for forming
TNF-induced high molecular weight RIP1 complex. This
complex/aggregate facilitates necroptosis.
ROS promotes RIP1 autophosphorylation on S161. It is known
that kinase activity of RIP1 is essential for TNF-induced
necroptosis and several phosphorylation sites in RIP1 have been
identiﬁed17,18,39,40. Here, we reconstituted RIP1 expression in
RIP1 KO L929 cells with WT, D138N (kinase dead mutant caused
by a mutation in activation loop), or KK-AT (kinase dead mutant
resulted from mutation of K45 and K46 in ATP pocket) RIP1
expression vector, respectively (Fig. 3a). As anticipated, the kinase
inactive forms of RIP1 cannot fully restore RIP1’s function as that
of WT; however, we could still detect a small amount of cell death
upon TNFþ zVAD treatment (Fig. 3b). Interestingly, the survival
curve of TNFþ zVAD-treated kinase-inactive cells was extremely
similar to that of WT cells treated with BHA or amytal.
Moreover, BHA and amytal had no effect on necroptosis of
RIP1 kinase-dead cells (Fig. 3b). These data drop a hint that the
function of BHA or amytal is probably to resemble inhibition
of RIP1 kinase activity. To test this possibility, we introduced
KK-AT mutation in RIP1DDD-HBD* and induced oligo-
merization of the RIP1DDD-HBD*-KK-AT in RIP1 KO L929
cells. The oligomerization of RIP1DDD-HBD*-KK-AT caused
cell death (Fig. 3c) although it occurred much slower than that
induced by the oligomerization of RIP1DDD-HBD* (Fig.1e), and
BHA and amytal could not inﬂuence RIP1DDD-HBD*-KK-AT-
caused cell death (Fig. 3c). Both RIP1DDD-HBD*and RIP1DDD-
HBD*-KK-AT mediated cell death are necroptosis because they
are RIP3- and MLKL-dependent (Supplementary Fig. 3a–c).
Thus, ROS’s function in necroptosis is very likely to be related to
RIP1 kinase activity.
RIP1 kinase activity is required for its autophosphorylation and
S14/15, S20, S161 and S166 have been identiﬁed as autopho-
sphorylation sites on RIP117. Yet the functional signiﬁcance of
those autophosphorylation sites has been debated since alanine
mutations show minimal effect on RIP1-dependent necro-
ptosis17,18. S161E mutation does gain resistance to Nec-1 in
necroptosis, but it is interpreted as a result of conﬁrmation
change rather than the phosphomemetic effect of E to bypass
RIP1 kinase activity. Since E or aspartic acid (D) mutation of S or
T in RIP1 may allow us to ﬁnd the phosphorylated RIP1 that can
bypass its kinase activity in necroptosis, we collected information
from literature, databases and our own MS analyses and found a
total of 40S/T as possible phosphorylation sites in mouse RIP1,
and mutated them to E. To our surprise, S161E mutant-
reconstituted L929 cell line is the only one that can effectively
undergo necroptosis and meanwhile is not sensitive to Nec-1
inhibition (Fig. 3d). To conﬁrm that phosphorylation of S161 in
RIP1 is inducible in TNF-induced necroptosis, we performed
quantitative MS analyses (Supplementary Fig. 3d,e) and revealed
hundreds-fold increase in S161 phosphorylation 2 h after TNF
stimulation in L929 cells (Fig. 3e). When BHA or amytal was
applied, phosphorylation of S161 was vanished, indicating that
ROS promote RIP1 autophosphorylation on S161 (Fig. 3e).
S161 phosphorylation is essential for RIP1 function. In refer-
ence to the structure of B-RAF, Degterev et al. modelled a
structure of RIP1 and predicted that S161 would form a hydrogen
bond with Glycine (G) 188, which might be important in keeping
RIP1 in an inactive status (closed conformation)17. Crystal
structure of RIP1 is available now, which indicates that S161
locates in the activation loop (T-loop) and its hydroxyl oxygen
can form hydrogen bond with carboxyl oxygen of D15638
(Supplementary Fig. 4a). Accordingly, alanine mutation of S161
should weaken its interaction with D156 and thus increase the
ﬂexibility of T-loop (Supplementary Fig. 4b). The ﬂexible
structure of S161A mutant should readily be changed to an
‘open conformation’ and therefore it is still able to mediate
TNF-induced necroptosis. Considering that serine possesses
structural characteristics such as hydrogen-bond formation and
polarity that alanine does not have, other investigators changed
the strategy and mutated serine to asparagine (N)41. We also used
this asparagine mutation to mimic S161 non-phosphorylated
RIP1. Asparagine in S161N mutant should be able to form
hydrogen bond with carboxyl oxygen of D156 (Supplementary
Fig. 4c). Phosphorylation of S161 (or S161E mutation) should
destroy the S161-D156 interaction and create an ‘open
conﬁrmation’ of T-loop (Supplementary Fig. 4d). To test this
prediction, we compared these mutants with WT and D138N
RIP1 for their ability to reconstitute RIP1 function in necroptosis
(Fig. 4a,b). Unlike the kinase dead mutation D138N, S161A
mutation only slightly reduced RIP1’s ability to mediate
TNF-induced necroptosis (Fig. 4b), which was consistent with
previous reports17,18. In agreement with our reasoning, S161N-
reconstituted cells were as resistant to TNF-induced necroptosis
as D138N-reconstituted cells (Fig. 4b). Furthermore, TNFþ
zVAD-induced necroptosis in S161E reconstituted L929 cells was
slightly quicker than that in WT-reconstituted cells (Fig. 4b).
These data suggest that S161 is a functional autophosphorylation
site of RIP1, which is required for RIP1 to efﬁciently mediate
necroptosis.
To further demonstrate that the primary function of RIP1
kinase activity in TNF-induced necroptosis is to phosphorylate
S161, we introduced S161E mutation in both KK-AT
and D138N mutants (KK-AT-S161E and D138N-S161E)
and expressed them, respectively, in RIP1 KO cells (Fig. 4c).
In contrast to KK-AT and D138N mutants, which cannot
effectively mediate necroptosis, TNF induced quick necroptosis
in KK-AT-S161E or D138N-S161E reconstituted RIP1 KO cells
(Fig. 4d). By now, it is clear that S161E mutation in RIP1 can
bypass the defect caused by kinase-dead mutation, and the
principal role of RIP1 kinase activity in necroptosis is to
autophosphorylate S161.
Then we proceeded to examine the effect of BHA and amytal
on TNF-induced necroptosis in S161E, S161N, S161A or KK-AT-
S161E reconstituted RIP1 KO cells. We found that BHA and
amytal can no longer inhibit cell death when autophosphoryla-
tion of S161 in RIP1 was prevented by E or N mutation in both
TNF- and RIP1 oligomerization-induced cell death (Fig. 4e–g,i,j),
indicating that ROS function to enhance RIP1 kinase activity and
the subsequent S161 autophosphorylation. However, BHA and
amytal still had inhibitory effect on TNFþ zVAD-induced cell
death in S161A reconstituted cells (Fig. 4h). This might be due to
that alanine mutation makes the T-loop more ﬂexible and allows
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phosphorylation on other site(s) to partially compensate the
function of S161 phosphorylation. Collectively, these data led to a
conclusion that ROS enhance S161 autophosphorylation of RIP1
and the S161 phosphorylation is required for RIP1 to efﬁciently
transduce necroptotic signal.
Cys-mediated RIP1 aggregation enhances S161 phosphorylation.
Since ROS cause RIP1 to form disulﬁde bond-linked aggregates
and ROS enhance S161 autophosphorylation of RIP1, we ana-
lysed the effect of disruption of disulﬁde bond-linked RIP1
aggregate by 3CS mutation on S161 autophosphorylation. RIP1
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Figure 3 | Identiﬁcation of S161 as an autophosphorylation site of RIP1 in response to ROS activation. (a) RIP1 KO L929 cells were infected with
lentivirus encoding Flag-tagged WT, KK-ATor D138N RIP1, respectively, for 24 h, and then subjected to western blotting for examination of expression level
of these proteins. Anti-RIP1 and anti-GAPDH antibodies were used. (b) RIP1 KO L929 cells carrying WT, KK-AT or D138N RIP1 were treated with
mTNFþzVAD for time as indicated with/without the presence of BHA/amytal. Viabilities were measured by PI exclusion. (c) RIP1 KO L929 cells
reconstituted with Flag-tagged RIP1DDD-HBD*-KK-AT were treated with 4-OHTþzVAD for indicated periods of time with or without BHA/amytal.
Viabilities were measured by PI exclusion. (d) RIP1 KO L929 cells were reconstituted with RIP1 carrying different serine/threonine mutations and stimulated
with mTNFþzVAD for 4 h. Necrostatin-1 (Nec-1) was used at 30mM to pretreat the cells for 1 h and then kept in the media till viabilities were measured by
PI exclusion. RIP1 expression levels were determined by western blotting with anti-RIP1 antibody. (e) Flag-tagged RIP1 reconstituted RIP1 KO L929 cells were
treated with mTNFþzVAD for 2 h with or without BHA/amytal followed by Flag immunoprecipitation and targeted MS analysis. Phosphopeptides
containing S161 phosphorylation were detected and the MS2 intensities of the S161 phosphopeptide in each sample were extracted and the relative folds
were calculated and shown. Data in (b–d) represented the mean±s.e.m. of three and two independent experiments, respectively. *Po0.05; **Po0.01; ns:
no signiﬁcant difference. See also Supplementary Fig. 3.
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KO L929 cells were reconstituted with WT or 3CS RIP1
expression and the phosphorylation level of S161 was measured
using quantitative MS analysis. We found that TNF-induced
increase of S161 phosphorylation was blocked by 3CS
mutation (Fig. 5a, Supplementary Fig. 5a), indicating that S161
phosphorylation is a downstream event of disulﬁde bond-medi-
ated RIP1 aggregation.
We then determined whether phosphomimetic S161 mutation,
S161E can bypass the inhibitory effect of 3CS mutation on
necroptosis. The same as the data shown in Fig. 2a,b, TNFþ
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Figure 4 | ROS promote RIP1 autophosphorylation on S161 and this phosphorylation is essential for RIP1 to effectively transduce necroptotic signal.
(a,c) RIP1 KO L929 cells were infected with lentivirus encoding Flag-tagged RIP1 WT, D138N, S161A, S161N, S161E, KK-AT-S161E and D138N-S161E,
respectively, for 24 h. Expression level of RIP1 was measured by western blotting with anti-RIP1 antibody. (b,d) Viabilities of each reconstituted cell line
were measured by PI exclusion after mTNFþzVAD treatment for different periods of time. (e–j) RIP1 KO L929 cells were infected with lentivirus encoding
Flag-tagged RIP1 S161E, S161N, KK-AT-S161E, S161A, RIP1DDD-S161E-HBD* or RIP1DDD-S161N-HBD*, respectively, for 24 h. Viabilities of each cell line were
determined at different time points under stimulation of mTNF/4-OHTþzVAD with or without BHA/amytal. Data in (b,d–j) represented the mean±s.e.m.
of three independent experiments. *Po0.05; **Po0.01; ns: no signiﬁcant difference. See also Supplementary Fig. 4.
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Figure 5 | 3CS mutation blocks S161 phosphorylation and S161E mutation can bypass the defect of 3CS mutation in necroptosis. (a) Flag-tagged RIP1
WT or 3CS reconstituted RIP1 KO L929 cells were treated with mTNFþzVAD for 2 h followed by Flag immunoprecipitation and targeted MS analysis.
Phosphopeptides containing phosphorylated S161 were detected and the MS2 intensities of the S161 phosphopeptide in each sample were extracted and
the relative folds were calculated and shown. (b) RIP1 KO L929 cells were infected with lentivirus encoding Flag-tagged WT, 3CS or 3CS-S161E RIP1 for 24 h.
Viabilities were determined at different time points after mTNFþzVAD treatment with or without BHA/amytal. The RIP1 expression were determined by
western blotting with anti-RIP1 antibody. (c) The same as in (b) except that the cells were infected with lentivirus encoding Flag-tagged RIP1DDD-HBD*,
RIP1DDD-HBD*-3CS or RIP1DDD -HBD*-3CS-S161E for 24 h. Viabilities were determined at different time points after 4-OHTþzVAD treatment with or
without BHA/amytal. (d) Flag-tagged WT, KK-AT or 3CS RIP1 was expressed in RIP1 KO HEK293T cells and puriﬁed by M2 beads. These proteins were
analysed by western blotting with anti-RIP1 antibody under reducing and non-reducing conditions. (e) Proteins described in (d) were pre-treated with
nothing, 10mM H2O2, or 1mM DTT for 10min at 20 C, and then in vitro kinase reactions of these proteins were performed by adding ATP to ﬁnal
concentration of 10mM and incubated at 30 C for 30min. The reaction was stopped by adding TCA to 20%. The TCA precipitates were subjected to
targeted MS analysis of S161 phosphorylation. The normalized abundances of S161 phosphopeptide were calculated by normalizing MS2 intensities of the
S161 phosphopeptide with that of RIP1 tryptic peptide DLKPENILVDRDFHIK. (f) RIP1 KO L929 cells reconstituted with Flag-RIP1 or Flag-RIP1 3CS-S161E were
treated with mTNFþzVAD for indicated periods of time. Western blotting with anti-RIP1 antibody was performed under non-reducing condition. Data in
(b,c) represented the mean±s.e.m. of two independent experiments. **Po0.01; ns: no signiﬁcant difference. Data shown in (d,f) are representatives of two
to three independent experiments. See also Supplementary Fig. 5.
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zVAD-induced necroptosis was much less in RIP1 KO cells
expressing 3CS RIP1 compared with the cells expressing WT
RIP1 (Fig. 5b). We observed dramatic enhancement of TNFþ
zVAD-induced necroptosis when S161E mutation was added to
3CS RIP1 (Fig. 5b). As anticipated, BHA and amytal had
inhibitory effect on necroptosis in WT but not 3CS or 3CS-S161E
RIP1 expressing cells (Fig. 5b). The same result was obtained in
RIP1 oligomerization-mediated necroptosis in L929 cells
(Fig. 5c). The effect of ROS on RIP1 and the function of RIP1
S161 autophosphorylation should also occur in some other cell
lines as similar effects of 3CS, KK-AT, S161E and KK-AT-S161E
mutations on necroptosis were observed in MEF cells (Supple-
mentary Fig. 5b).
To examine whether the oxidation of cysteines in RIP1 can
enhance S161 phoshorylation in vitro, we expressed Flag-tagged
WT, KK-AT and 3CS RIP1 in HEK293T cells and puriﬁed these
proteins, respectively, by anti-Flag M2 agarose beads for in vitro
kinase assay. The enrichment of RIP1 and its mutant proteins on
the M2 beads may have drawn close the protein molecules,
therefore the immunopuriﬁed proteins formed disulﬁde bond-
linked complexes during the immunopuriﬁcation (Fig. 5d). The
disulﬁde bonds in those puriﬁed proteins were not restricted to
those formed by C257, C268 and C586 since the disulﬁde bond-
dependent shifts were also observed in 3CS mutant (Fig. 5d). To
eliminate disulﬁde bonds in the puriﬁed proteins, we pre-treated
the proteins with Dithiothreitol (DTT). We also included H2O2
treatment to increase the oxidation of the proteins. The pre-
treated and not pre-treated WT, KK-AT and 3CS RIP1 proteins
were then incubated with ATP to carry out autophosphorylation
reaction, respectively. Quantitative MS was used to determine the
levels of S161 phosphorylation after the in vitro kinase reaction.
The S161 in WT RIP1 complexes was already phosphorylated to a
certain level in the ATP-null control sample (Fig. 5e,
Supplementary Fig. 5c). This was not surprising because disulﬁde
bonds in the WT RIP1 complexes should contain those formed by
C257, C268 and C586, which can promote S161 autopho-
sphorylation (Fig. 5a). In vitro incubation of the WT RIP1
complexes with ATP increased S161 phosphorylation (Fig. 5e,
Supplementary Fig. 5c). H2O2 treatment further enhanced S161
phosphorylation in WT RIP1, and in contrast, DTT treatment
abolished the in vitro kinase reaction-caused increase of S161
phosphorylation (Fig. 5e, Supplementary Fig. 5c). S161 phos-
phorylation was not detected in control sample of KK-AT mutant
and in vitro kinase reaction did not lead to S161 phosphorylation,
demonstrating that S161 phosphorylation is an autophosphoryla-
tion event (Fig. 5e, Supplementary Fig. 5c). S161 phosphorylation
was not detected in control sample of 3CS mutant and in vitro
kinase reaction did not lead to S161 phosphorylation in 3CS
complexes, supporting the role of oxidation of three speciﬁc
cysteines in promoting S161 phosphorylation (Fig. 5e,
Supplementary Fig. 5c). Collectively, the in vitro kinase assay
supports the conclusion that the formation of speciﬁc disulﬁde
bond-linked complex promotes RIP1 S161 autophosphorylation.
As 3CS mutant cannot form high molecular weight aggregate
(Fig. 2d), but 3CS-S161E did efﬁciently mediate necroptosis
(Fig. 5b,c), we checked whether 3CS-S161E formed aggregate
during necroptosis induction. As shown in Fig. 5f, 3CS-S161E
cannot form disulﬁde bond-linked high molecular weight
complex. Thus, formation of disulﬁde bond-linked RIP1
aggregate is to enhance RIP1 S161 phosphorylation and is not
required for the signal transduction once S161 is already
phosphorylated.
RIP1 S161 phosphorylation enhances necrosome formation.
RIP1 participates in the formation of TNFR1 complex (complex I)
and necrosome during necroptosis. We examined TNF-induced
complex I formation in RIP1 KO cells reconstituted with WT,
3CS, 3CS-161E, KK-AT or KK-AT-S161E RIP1 expression, and
found no difference among these cell lines in recruiting RIP1,
TRAF2 and TRADD to TNFR1 (Supplementary Fig. 6a–b),
indicating that RIP1 oxidation and S161 phosphorylation has no
effect on complex I formation.
The core components of necrosome are RIP1 and RIP3. To
detect necrosome formation more easily, we knocked in a Flag tag
at the N-terminal of Rip1 in L929 cell line by homologous
recombination. This Flag-RIP1 L929 cell line behaved similarly to
the parental wild-type L929 in TNF-induced necroptosis
(Supplementary Fig. 6c). We performed immunoprecipitation
with anti-FLAG M2 beads from cell lysate of Flag-RIP1 L929 cells
treated with TNFþ zVAD for different periods of time, and
detected necrosome formation as indicated by co-immunopreci-
pitation of RIP3 and FADD (Fig. 6a,b). Both BHA and amytal
inhibited TNF-induced formation of necrosome, which is
consistent with a recent report that BHA inhibited TNFþ Smac
mimetic-induced necrosome formation22. In addition, BHA and
amytal had the same effect on TNF alone-induced necroptosis in
L929 cells (Supplementary Fig. 6d–e). We also analysed
TNF-induced necrosome formation in HeLa-RIP3 cell line, and
as predicted, both BHA and amytal had inhibitory effect on
human TNF-induced necrosome formation (Supplementary
Fig. 6f–g).
Next, we evaluated the effect of various RIP1 mutations on
necrosome formation. We immunoprecipitated necrosome from
WT, KK-AT or S161N RIP1 reconstituted RIP1 KO L929 cells
(Fig. 6c), and from WT or 3CS RIP1 reconstituted RIP1 KO cells
(Fig. 6d). Analysis of the necrosome revealed that both
deprivation of S161 phosphorylation and prevention of disulﬁde
bond formation inhibited necrosome formation (Fig. 6c,d).
Interestingly, when phosphomimetic mutation S161E was added
to KK-AT or 3CS mutant, the inhibitory effect was bypassed as
TNFþ zVAD-induced necrosome formation in these cells was
restored to a level similar to that of WT RIP1-expressing cells
(Fig. 6e,f). Consistent with the notion that S161 phosphorylation
is a downstream event of ROS-mediated enhancing effect in the
necroptosis pathway, BHA had no inhibitory effect on TNFþ
zVAD-induced necrosome formation in 3CS-S161E and KK-AT-
S161E RIP1 expressing cells (Fig. 6g,h). Collectively, these data
demonstrated that S161 phosphorylation of RIP1 positively
regulates necrosome formation.
Rip1 S161 phosphorylation facilitates RIP1-RIP3 co-localization.
To observe RIP1–RIP3 interaction visually, we used confocal
microscopy. To stain RIP1 and RIP3, we generated RIP1-RIP3-
double-knockout L929 (DKO L929) cell line and reconstituted it
with Flag-tagged RIP3 and HA-tagged RIP1. As shown in Fig. 7a,
TNFþ zVAD induced RIP1 and RIP3 co-localization and both
BHA and amytal inhibited RIP1 and RIP3 co-localization. Simi-
larly, no co-localization of RIP1 and RIP3 was observed in cells
bearing 3CS (Fig. 7b), KK-AT or S161N mutant (Fig. 7c).
In agreement with the co-immunoprecipitation data (Fig. 6),
3CS-S161E and KK-AT-S161E mutant of RIP1 bypassed the
kinase-dead defect as we observed co-localization of RIP1 with
RIP3 (Fig. 7b,c). Therefore, eliminating RIP1 autopho-
sphorylation inhibits TNFþ zVAD-induced co-localization of
RIP1and RIP3.
It is known that necroptosis signalling is mediated by
sequential events of RIP1–RIP1 homo-interaction, RIP1–RIP3
hetero-interaction and RIP3–RIP3 homo-interaction35. To
test whether the lack of RIP1–RIP3 interaction/co-localization
observed in Figs 6 and 7 is due to that S161 non-phosphorylated
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RIP1 cannot interact with other proteins in necrosome, we
compared WT, KK-AT and KK-AT-S161E RIP1 in their
interaction with RIP3, FADD or RIP1 itself by co-expressing
them in RIP1 KO HEK293 T cell line and performing
co-immunoprecipitation assay. These mutations did not alter
the interaction of RIP1 with other proteins (Supplementary
Fig. 7a–c). We also compared the interaction of WT and KK-AT
RIP1 with several ubiquitination-related proteins including
cIAP1, CYLD, xIAP, MIB1, ITCH and RNF31, which were
reported to regulate RIP1 in complex formation. We found that
RIP1 interacted with some of these enzymes and KK-AT
mutation had no effect on these interactions (Supplementary
Fig. 7d). Thus, how S161 phosphorylation of RIP1 affects the
recruitment of RIP3 to necrosome might not be as simple as the
change of RIP1’s afﬁnities with necrosome-associated proteins.
Discussion
Published data have suggested that the involvement of ROS in
necroptosis is cell type-dependent7,23,25,29–31. Our data support
this conclusion. It was known that TNF-induced ROS production
is RIP3 dependent8, and ROS function in a positive feedback loop
to enhance necrosome formation22. We discovered in this study
that ROS promote RIP1 autophosphorylation on S161 and
cysteine 257, 268 and 586 in RIP1 are required for ROS to
regulate RIP1. These three cysteines are required for the
formation of disulﬁde bond-linked high molecular weight
aggregate of RIP1 to enhance RIP1 S161 autophosphorylation,
which then facilitates necrosome formation. A proposed model is
shown in Fig. 7d. Since ROS induction is downstream of RIP3
activation, there could be other mechanism(s) to initiate
autophosphorylation of RIP1 in the early signalling stage. As
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Figure 7 | ROS as well as S161 phosphorylation of RIP1 facilitate RIP1-RIP3 co-localization in the cells undergoing TNF-induced necroptosis. (a) RIP1
and RIP3 DKO L929 cells reconstituted with HA-RIP1-WTand Flag-RIP3 were treated with mTNFþzVAD with or without the presence of BHA/amytal. Two
hours after TNF stimulation, cells were ﬁxed and immunostained for HA and RIP3 simultaneously and then subjected to confocal microscopy. (b,c) RIP1 and
RIP3 DKO L929 cells reconstituted with Flag-RIP3 were then reconstituted with HA-RIP1 3CS, 3CS-S161E, KK-AT, S161N, KK-AT-S161E. The cells were
treated with or without mTNFþzVAD for 2 h, and then ﬁxed and immunostained for HA and RIP3 simultaneously. (d) A proposed model for how ROS lead
to RIP1 autophosphorylation, which enhances TNF-induced necroptosis. Scale bar: 3mm. The images are representatives of pictures taken from at least 10
ﬁelds. See also Supplementary Figs 6,7.
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kinase-dead RIP1 can still mediate a low level of cell death,
non-phosphorylated RIP1 should be able to recruit a small
amount of RIP3. Therefore other mechanism(s) may not be
necessary because even a small amount of RIP3-dpendent ROS
should be capable of initiating a positive feedback loop on RIP1 to
promote S161 phosphorylation. Our data demonstrated that S161
is at least the major if not the only functional phosphorylation site
in RIP1 during necroptosis and the S161 phosphorylation enables
RIP1 to efﬁciently recruit more RIP3. Published data already
showed that autophosphorylation of RIP3 occurs in necrosomes
containing RIP3 homo-oligomers, which recruit and phospho-
rylate MLKL, and ﬁnally, the phosphorylated MLKL executes
necroptosis.
RIP3 in necrosome is pro-necroptosis but caspase-8 in this
signalling complex is anti-necroptosis. The role of RIP1 in this
complex could be pro-apoptotic or pro-necroptotic depending on
whether it only recruits caspase-8 via FADD or it also efﬁciently
recruits RIP3 (ref. 4). The positive feedback on RIP1 phospho-
rylation by RIP3-dependent ROS is crucial for balancing the
signalling toward necroptosis in cells like L929. And RIP1 is most
likely to be the sole target of ROS in necroptosis, since KO of A20,
CYLD, TRAF2, USP13, TRADD, NEMO, IKKb, Caspase-8 or
FADD in L929 cells did not affect BHA- or amytal-mediated
inhibition of TNFþ zVAD-induced necroptosis. We believe that
S161 phosphorylation of RIP1 should be a common event in
RIP1-mediated necroptosis regardless of whether ROS are
involved or not, and there should be other mechanism(s) that
promote(s) S161 phosphorylation. We also noticed that RIP1 3CS
mutant still mediated TNF-induced necroptosis to a level higher
than that mediated by kinase dead mutants (Figs 2b and 3b),
supporting the idea that ROS is not the sole regulator of RIP1
autophosphorylation. Moreover, RIP1 kinase activity may have
additional function in promoting necroptosis since we noticed
that TNF-induced cell death in RIP1 KO cells carrying KK-AT-
S161E RIP1 was not as quick as that in cells carrying S161E RIP1
(Fig. 4d). Multiple factors, including Caspase-8 inactivation/
inhibition, RIP3 level in cells and ROS-mediated RIP1 S161
phosphorylation, are determinants of necroptosis, but not all of
these factors are necessary for the function of necrosome in
certain cell types. An example is that mitochondrial ROS is not
involved in TNF-induced necroptosis in HT-29, 3T3-SA and
SEVC cells7,29.
Using Parkin-induced mitochondrial depletion, Tait et al.
found that elimination of mitochondria had no effect on TNFþ
zVAD-induced necroptosis in a couple of cell lines29. Their data
do not conﬂict with the conclusion that the ROS involvement in
necroptosis is cell context-dependent. The underlying mechanism
of this cell type dependence awaits further investigation. The
updated data agree that ROS do not cause cell death directly, but
by regulating necroptotic pathway. A number of reports showed
that RIP1 kinase activity is required for apoptosis42–44. Since TNF
can induce RIP1-dependent and -independent apoptosis, whether
S161 autophosphorylation is required for TNF-induced RIP1-
dependent apoptosis awaits further investigation.
It was reported recently that activated IKKa/IKKb can inhibit
RIP1 translocation from TNF receptor complex (complex I) to
complex II in TNF-induced apoptosis by phosphorylating RIP1 in
complex I43. By using IKKa/IKKb inhibitor TPCA-1 and
TAK1 inhibitor (5Z)-7-Oxozeaenol or RIP1-TAK1 double KO
(RIP1-TAK1 DKO) L929 cells that were sequentially reconstituted
with TAK1 and RIP1 mutants, we found that RIP1 phos-
phorylation by IKKa/IKKb inhibited TNFþ zVAD-induced
necroptosis (Supplementary Fig. 8a–c), similar to what was
observed in TNF-induced apoptosis43. Interestingly, the effect of
TAK1-IKKa/IKKb inhibition on necroptosis was eliminated
in the cells expressing KK-AT, KK-AT-S161E or S161E RIP1
(Supplementary Fig. 8a–c). And we knew that TNF-induced
complex I formation was not affected by kinase-dead or S161
phosphomimetic mutation of RIP1 (Supplementary Fig. 6b).
Since autophosphorylation is mediated by RIP1 kinase activity
and the common consequence of both KK-AT and S161E is
diminished S161 phosphorylation, IKKa/IKKb-mediated
phosphorylation of RIP1 most likely inhibits RIP1 autophos-
phorylation. KK-AT mutant cannot autophosphorylate and thus
cannot be regulated by IKKa/IKKb. S161E mimics the phos-
phorylated form of RIP1 and thus overcomes inhibitory effect of
IKKa/IKKb on RIP1-mediated necroptosis. There are many
phosphorylation sites in RIP1, including the autophosphorylation
sites and those targeted by IKKa/IKKb. Some low-mobility forms
of RIP1 were showed to be phosphorylated, and band-shift of
RIP1 on electrophoresis gels was widely used as an indicator of
RIP1 phosphorylation43,45. But S161 phosphorylation contributes
very little if there is any to the mobility changes of RIP1.
In conclusion, our study uncovered the mechanism of RIP3-
dependent ROS in promoting necroptosis and identiﬁed key
residues on RIP1 to sense redox signals. Our data provided new
insight into the role of RIP1 S161 autophosphorylation in
controlling the proper formation of necrosome. We believe that
cell fate is determined by the balance of multiple factors in
necrosome and we have demonstrated RIP1 S161 phosphoryla-
tion as an essential pro-necroptotic event.
Methods
Cell lines and cell culture. Mouse ﬁbrosarcoma L929, HeLa, human embryonic
kidney (HEK) 293T, U937 and HT-29 cells were obtained from ATCC (Manassas,
VA, USA). The A cell line is the NIH3T3 cell line obtained from ATCC. The N cell
line is an NIH3T3 cell line obtained from Dr Sabine Adam-Klages at Universitat
Kiel, Germany. This NIH3T3 cell line originated from the same cell line as A cells
and was shown to undergo caspase-independent cell death in response to TNF8.
Primary peritoneal macrophages elicited by thioglycollate medium were generated
from wildtype C57BL/6 mice at the age of 8–12 weeks. MEF cell lines were isolated
from wildtype mouse embryos at 13.5 dpc (days post conception). RIP1 KO
HEK293T, as well as all of the gene KO L929 cell lines, was constructed by TALEN
or CRISPR/Cas9 method. The target site for RIP1 was designed as ‘CTACTACAT
GGCGCCCGAGC’, the target site for TNFR1 was ‘GCTTCAACGGCACCG
TGAC’, the target site for RIP3 was designed as ‘CTAACATTCTGCTGGA’. For
MLKL, the target sites was designed as ‘ATCATTGGAATACCGT’15,46,47, and the
KO cell lines were veriﬁed by sequencing of the targeted loci. RIP1 of L929 was
knocked in with a Flag tag at its N-terminal by homologous recombination with
the sequence of ‘DYKDDDDK’. U937 was kept in ATCC-formulated RPMI-1640
medium, while others were maintained in DMEM, supplemented with 10%
fetal bovine serum, 2mM l-glutamine, non-essential amino acids to a ﬁnal
concentration of 0.1mM, 100 IU penicillin and 100mg/ml streptomycin, at 37 C
in humidiﬁed incubator with 5% CO2. All the cell lines were authenticated by
morphology and DNA sequencing, and were repeatedly tested to be mycoplasma-
free as judged by the MycoAlert Mycoplasma Detection Kit (Lonza, LT-07).
Reagents and antibodies. Alexa Fluor 647 Goat Anti-mouse IgG (Hþ L)
secondary antibody (1:100, A-21236) and Alexa Fluor 488 Goat Anti-rabbit IgG
(Hþ L) Antibody (1:100, A11034) were purchased from Invitrogen (Carlsbad,
CA USA). Propidium iodide (PI), BHA, 4-hydroxytamoxifen (4-OHT), CCCP and
5Z-7-Oxozeaenol were from Sigma (St. Louis, MO, USA). TPCA-1 was from Tocris
Bioscience (Ellisville, MO, USA). Benzyloxycarbonyl-Val-Ala-Aspﬂuoromethylk-
etone (zVAD) was from Calbiochem (San Diego, CA, USA). Mouse and human
TNFa were from eBioscience (San Diego, CA, USA). Amytal sodium was from
Marathonpharma (Northbrook, IL, USA). Mouse anti-HA (F-7), mouse anti-
GAPDH (6C5), Tak1 (M-579), TRADD (H-278), TRAF2 (C-20), rabbit anti-
Tom20 (FL-145) antibodies were purchased from Santa Cruz Biotechnology, Inc.
(Dallas, Texas, USA), and used at a concentration of 1:500. b-Tubulin (1:1,000,
10B1) Mouse mAb was from Abmart (Berkeley Heights, NJ, USA). TNF-R1
(1:500, D3I7K) Rabbit mAb (Rodent Speciﬁc) were purchased from Cell Signaling
Technology, Inc. (Danvers, MA, USA). Mouse anti-FLAG M2 and mouse anti-HA
beads, mouse anti-FLAG (M2) antibodies were purchased from Sigma. Mouse
anti-RIP1 antibody (1:1,000, 610459) was obtained from BD Biosciences (San Jose,
CA, USA). Rabbit anti-mRIP3 (1:1,000) and rabbit anti-mFADD (1:1,000)
antibodies were raised using E. coli-expressed GST-RIP3 (287-387 amino acid)
and GST-FADD (full length), respectively8,15. Rabbit anti-human RIP3 (hRIP3)
antibodies (1:1,000, ab72106) were purchased from Abcam (Cambridge
Cambridgeshire, UK). Human RIP1 antibody (1:1,000) was raised in rabbit using
amino acids 555-671. For Flag-tagged mTNF preparation, matured mouse TNFa
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(a truncated form of prematured mouse TNFa from 77-235a.a.) was cloned into
pET28a vector between NcoI and XhoI enzymatic sites with an N-terminal fused
3xFlag tag. Protein expression in BL21de3 was carried out overnight at 30 C
in auto-induction medium. Then the lysates were ﬁrst puriﬁed by ammonium
sulfate precipitation. Soluble fraction from 30–65% saturation of ammonium
sulfate was further puriﬁed with M2 beads. After eluted with 3xFLAG peptide
(Sigma), proteins were ﬁnally puriﬁed with Superdex-75 120ml prepacked column
(GE Healthcare, Little Chalfont, UK).
Plasmids construction. YFP-Parkin (plasmid #23955) was purchased from
Addgene (Cambridge, MA, USA). Full-lengths of TAK1, RIP1, mouse/human RIP3,
FADD and UB-related genes were ampliﬁed from our cDNA library. To
generate fusion proteins, HBD*(G521R), tTNFR1, RIP1DDD, RIP3-RHIMmut and
MLKLDPD were ampliﬁed by standard PCR from corresponding templates. RIP1
mutations (D138N, KK-AT, S161A, S161E, S161N etc.) were introduced by
two-round PCR. Lentiviral vector used was pBOB (Addgene plasmid #12337),
which had been modiﬁed by inserting DNA fragments encoding Flag/HA tag.
pBOB was used as plasmid backbone for all of the constructs in this study. Exo
III-assisted ligation-independent-cloning method48 was used for all subcloning. All
plasmids were veriﬁed by DNA sequencing. The details of the plasmids sequences
are available upon request.
Immunoprecipitation and western blotting. For complex I or necrosome
immunoprecipitation, cells were seeded in a 100mm tissue culture plate, grew to
reach conﬂuency and then were treated with 10 ng/ml Flag-mTNF or mTNF þ
zVAD (20mM) for different periods of time. After treatment, cells were scrapped
from the plates and rinsed twice with ice-cold PBS and lysed with buffer published
before35. Cell lysates were centrifuged at 20,000 g for 30min, and the
supernatants were subjected to immunoprecipitation with mouse anti-Flag M2
beads or anti-HA beads at 4 C overnight. The beads were then washed three times
in lysis buffer the next day and the 1.2X Laemmli buffer eluted proteins were then
analysed by routine western blotting. Uncropped scans of blots were supplied as
Supplementary Fig. 9 in the supplementary information.
Cell viability assay. Cells were trypsinized to suspended single cells from tissue
culture plates and incubated with 5 mgml 1 PI in PBS for 10min. PI negative cells
(indicating living cells) were analysed by FACS (BD Calibur; or Beckman Coulter
EPICS XL) with excitation/emission maxima of 535/617 nm approximately.
Measurement of oxygen consumption rate. Oxygen consumption rates of cells
were measured by the Seahorse Bioscience Extracellular Flux Analyzer (XF96;
Seahorse Bioscience) according to manufacturer’s protocol. Brieﬂy, 8,000
cells (each well) were cultured overnight in custom XF96 microplates. Before
measurement, cells were washed, and immersed in fresh medium for 1 h. The assay
procedure was set as ‘Mix-03:00, Wait-00:00, Measurement-03:00’ for 10 cycles.
After measurement, cells were trypsin-digested and counted for cell number.
Oxygen consumption rates of cells were normalized to cell number.
Measurement of ROS. Cells were cultured and treated with indicated stimuli.
After treatment, the cells were washed with warm PBS, removed from the plates
with trypsin-EDTA, pelleted at 200 g for 3min, re-suspended in Hank’s balanced-
salt solution containing 5 mM MitoSOX for 10min and analysed by ﬂow cytometry
with excitation/emission maxima of approximately 510/580 nm.
In vitro kinase assay. In vitro kinase reaction was performed in buffer containing
40mM Tris, pH 7.5, 20mM MgCl2, 0.1mM Na3VO4, 10 mM ATP.
Sample preparation for confocal microscopy. Reconstituted RIP1-RIP3 DKO
L929 was seeded on circular cover glass (72222-01, Electron microscopy science,
Hatﬁeld, PA, USA) pretreated with Poly-L-lysine hydrobromide (Sigma) for
15min. After stimulated with mTNFþ zVAD for 2 h, cells were washed with PBS
three times, and ﬁxed with 3% paraformaldehyde for 20min at room temperature
(RT). 0.25% Triton X-100 was then used to break cell membrane for 10min at RT.
These ﬁxed samples were then washed with PBS and blocked with 3% BSA for
30min at RT. After aspiration of blocking buffer, primary anti-HA (mouse, 1:100)
and anti-RIP3 (Rabbit, 1:100) antibodies diluted in blocking buffer were used at
4 C overnight. The samples were then washed ﬁve times with PBS at RT and then
subjected to ﬂuorescence-labelled secondary antibodies, goat anti-mouse Alexa-
Fluor 647 and goat anti-rabbit AlexaFluor 488. This incubation should be protected
from light for 60min at RT. Cells were then washed three times with PBS and then
stored in PBS, ready for confocal analysis. All images were captured and processed
using identical settings in the Zeiss LSM 780 laser scanning confocal microscope
with a 63 /1.40 NA oil objective. Duplicate cultures were examined, and similar
results were obtained in at least three independent experiments.
Determination of S161 phosphorylation by mass spectrometry. Flag-RIP1 was
immunoprecipitated with M2 beads from mTNFþ zVAD treated RIP1 KO L929
cells expressing Flag-RIP1. Proteins in IP samples were precipitated with 10% TCA,
and then washed three times with iced acetone. Proteins were then dissolved in
8M urea/50mM NH4HCO3, and disulﬁde bonds were reduced with 10mM tris
(2-carboxyethyl)phosphine (TCEP) followed by alkylation with 40mM chlor-
oacetamide. After 8M urea was diluted to 2M urea with 50mM NH4HCO3,
trypsin was added with a protein to trypsin ratio of 50:1, and digestions
were performed at 37 C for 12–16 h. Two synthetic phosphopeptides,
pSRTPPSAPSQSR and GHLpSEGLVTK (50 fmole each), were added into the
samples as internal controls for the quantitation of phosphopeptides. Tryptic
peptides were desalted with C18 STAGEtip followed by phosphopeptide enrich-
ment using immobilized metal afﬁnity chromatography as described previously49.
Brieﬂy, peptides were dissolved in 50 ml 60% ACN (acetonitrile)/1% AA (acetic
acid), and then 5 ml immobilized metal afﬁnity chromatography beads were added.
The tubes were rigorously shaken for half an hour. Then beads were washed
with 60% CAN/1% AA whose volume was twofold of beads volume. The
phosphopeptides were eluted with 6% NH3H2O the volume of which was threefold
of beads volume.
Phosphopeptides were analysed using MS tripleTOF 5600. To quantify RIPK1
phosphopeptide containing S161, MS was operated in high-resolution MRM mode.
The m/z values of the precursor ions representing RIP1 S161 and two synthetic
phosphopeptides were in the inclusion list. The MS1 scan was 0.25 s and covered
350–1,250, and MS2 scan of three precursor ions was 0.5 s and covered 100–1,800,
resulting in the cycle time of 1.75 s. The collision energy of each precursor ion was
calculated using the equation: |CE|¼ (0.044)*(m/z)þ 4 for the peptides with þ 2
charge, and |CE|¼ (0.05)*m/zþ 3 for the peptides with þ 3 charge. MS data
analyses were performed with Peakview (version 2.2) software.
Identiﬁcation of cysteine modiﬁcation by mass spectrometry. RIPK1
complexes were puriﬁed with M2 beads in Flag-RIP1 reconstituted L929 cells.
During IP, 10mM N-ethylmaleimide was added. RIP1 was eluted with SDS
sample buffer containing no reducing agent followed by SDS-PAGE. The gels
corresponding to aggregated RIP1 or monomer RIP1 were excised and cut into
cubes. Proteins were further reduced with 10mM Tris(2-carboxyethyl) phosphine
hydrochloride for 20min, followed by treatment with 30mM iodoacetamide for
20min. Sequencing grade soluble trypsin was used for digestion. The resulting
peptides were subjected to MS analysis. The data-dependent tandem MS analysis
was performed in a Triple TOF 5600 (Sciex). The MS1 scan is 0.25 s and covers
350–1,250, and 20 precursor ions are selected for MS2 analysis and covers
100–1,800, resulting in the cycle time of 1.25 s. MS data were searched with
ProteinPilot Software (V.4.5).
Statistical evaluation. Statistical analysis was performed with Prism software
(GraphPad Software). Data are represented as means±s.e.m. Two-tailed Student’s
t-test was used to compare differences between treated groups and their paired
controls. Differences in compared groups were considered statistically signiﬁcant
with P values lower than 0.05; *Po0.05; **Po0.01.
Data availability. All relevant data are available from the authors and data in the
manuscript are available as source data.
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